Pt Kalbe Farma Stock Fundamentals
| PTKFF Stock | USD 0.1 0.00 0.00% |
PT Kalbe Farma fundamentals help investors to digest information that contributes to PT Kalbe's financial success or failures. It also enables traders to predict the movement of PTKFF Pink Sheet. The fundamental analysis module provides a way to measure PT Kalbe's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Kalbe pink sheet.
PTKFF |
PT Kalbe Farma Company Return On Equity Analysis
PT Kalbe's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PT Kalbe Return On Equity | 0.17 |
Most of PT Kalbe's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PT Kalbe Farma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, PT Kalbe Farma has a Return On Equity of 0.1673. This is 100.7% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on equity for all United States stocks is 153.97% lower than that of the firm.
PT Kalbe Farma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PT Kalbe's current stock value. Our valuation model uses many indicators to compare PT Kalbe value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PT Kalbe competition to find correlations between indicators driving PT Kalbe's intrinsic value. More Info.PT Kalbe Farma is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for PT Kalbe Farma is roughly 1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PT Kalbe's earnings, one of the primary drivers of an investment's value.PTKFF Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PT Kalbe's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PT Kalbe could also be used in its relative valuation, which is a method of valuing PT Kalbe by comparing valuation metrics of similar companies.PT Kalbe is currently under evaluation in return on equity category among its peers.
PTKFF Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Current Valuation | 6.11 B | |||
| Shares Outstanding | 46.26 B | |||
| Shares Owned By Insiders | 58.08 % | |||
| Shares Owned By Institutions | 15.23 % | |||
| Price To Book | 5.15 X | |||
| Price To Sales | 3.56 X | |||
| Revenue | 26.26 T | |||
| Gross Profit | 11.11 T | |||
| EBITDA | 4.54 T | |||
| Net Income | 3.18 T | |||
| Cash And Equivalents | 189.29 M | |||
| Total Debt | 490.28 B | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 4.08 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 2.83 T | |||
| Number Of Employees | 12.64 K | |||
| Beta | 0.32 | |||
| Market Capitalization | 7.34 B | |||
| Total Asset | 25.67 T | |||
| Retained Earnings | 10.82 T | |||
| Working Capital | 6.76 T | |||
| Current Asset | 9.22 T | |||
| Current Liabilities | 2.46 T | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 25.67 T |
About PT Kalbe Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Kalbe Farma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Kalbe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Kalbe Farma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.
Currently Active Assets on Macroaxis
Other Information on Investing in PTKFF Pink Sheet
PT Kalbe financial ratios help investors to determine whether PTKFF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PTKFF with respect to the benefits of owning PT Kalbe security.